• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一种新的等效概率加权幂先验方法,用于自适应临床试验设计中使用历史对照数据:与标准方法的比较。

A novel equivalence probability weighted power prior for using historical control data in an adaptive clinical trial design: A comparison to standard methods.

机构信息

MRC Biostatistics Unit, University of Cambridge, Cambridge, UK.

Department of Psychiatry, University of Cambridge, Cambridge, UK.

出版信息

Pharm Stat. 2021 May;20(3):462-484. doi: 10.1002/pst.2088. Epub 2021 Jan 20.

DOI:10.1002/pst.2088
PMID:33474798
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8611797/
Abstract

A standard two-arm randomised controlled trial usually compares an intervention to a control treatment with equal numbers of patients randomised to each treatment arm and only data from within the current trial are used to assess the treatment effect. Historical data are used when designing new trials and have recently been considered for use in the analysis when the required number of patients under a standard trial design cannot be achieved. Incorporating historical control data could lead to more efficient trials, reducing the number of controls required in the current study when the historical and current control data agree. However, when the data are inconsistent, there is potential for biased treatment effect estimates, inflated type I error and reduced power. We introduce two novel approaches for binary data which discount historical data based on the agreement with the current trial controls, an equivalence approach and an approach based on tail area probabilities. An adaptive design is used where the allocation ratio is adapted at the interim analysis, randomising fewer patients to control when there is agreement. The historical data are down-weighted in the analysis using the power prior approach with a fixed power. We compare operating characteristics of the proposed design to historical data methods in the literature: the modified power prior; commensurate prior; and robust mixture prior. The equivalence probability weight approach is intuitive and the operating characteristics can be calculated exactly. Furthermore, the equivalence bounds can be chosen to control the maximum possible inflation in type I error.

摘要

一项标准的双臂随机对照试验通常将干预措施与对照治疗进行比较,将等量的患者随机分配到每个治疗组中,仅使用当前试验内的数据评估治疗效果。在设计新试验时会使用历史数据,并且最近已经考虑在标准试验设计无法达到所需患者数量时将其用于分析。纳入历史对照数据可能会使试验更有效率,当当前研究的对照数据与历史数据一致时,可以减少当前研究中所需的对照数量。然而,当数据不一致时,可能会导致治疗效果估计值存在偏差、Ⅰ型错误率增加和效力降低。我们提出了两种新的二项数据方法,根据与当前试验对照的一致性对历史数据进行折扣,一种是等效方法,另一种是基于尾部区域概率的方法。采用适应性设计,在中期分析时调整分配比例,当存在一致性时,减少对照患者的随机分配。使用固定效力的功效先验方法对分析中的历史数据进行降权。我们将拟议设计的操作特征与文献中的历史数据方法进行比较:修改后的功效先验;相称先验;和稳健混合先验。等效概率权重方法直观,操作特征可以精确计算。此外,可以选择等效界限来控制Ⅰ型错误率的最大可能膨胀。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d5de/8611797/b7c7a050f906/PST-20-462-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d5de/8611797/bb8cebab270a/PST-20-462-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d5de/8611797/5e32e65cc951/PST-20-462-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d5de/8611797/b8ea576b36e6/PST-20-462-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d5de/8611797/fda58c3a7fd1/PST-20-462-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d5de/8611797/e2d2de124660/PST-20-462-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d5de/8611797/399f1e2ced0c/PST-20-462-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d5de/8611797/3d0c5871e394/PST-20-462-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d5de/8611797/c09b08bc59ef/PST-20-462-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d5de/8611797/b7c7a050f906/PST-20-462-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d5de/8611797/bb8cebab270a/PST-20-462-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d5de/8611797/5e32e65cc951/PST-20-462-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d5de/8611797/b8ea576b36e6/PST-20-462-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d5de/8611797/fda58c3a7fd1/PST-20-462-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d5de/8611797/e2d2de124660/PST-20-462-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d5de/8611797/399f1e2ced0c/PST-20-462-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d5de/8611797/3d0c5871e394/PST-20-462-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d5de/8611797/c09b08bc59ef/PST-20-462-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d5de/8611797/b7c7a050f906/PST-20-462-g003.jpg

相似文献

1
A novel equivalence probability weighted power prior for using historical control data in an adaptive clinical trial design: A comparison to standard methods.一种新的等效概率加权幂先验方法,用于自适应临床试验设计中使用历史对照数据:与标准方法的比较。
Pharm Stat. 2021 May;20(3):462-484. doi: 10.1002/pst.2088. Epub 2021 Jan 20.
2
Critical appraisal of Bayesian dynamic borrowing from an imperfectly commensurate historical control.贝叶斯动态借用不完美匹配历史对照的批判性评价。
Pharm Stat. 2020 Sep;19(5):613-625. doi: 10.1002/pst.2018. Epub 2020 Mar 17.
3
Bayesian selective response-adaptive design using the historical control.基于历史对照的贝叶斯选择反应适应性设计。
Stat Med. 2018 Nov 20;37(26):3709-3722. doi: 10.1002/sim.7836. Epub 2018 Jun 13.
4
Incorporating individual historical controls and aggregate treatment effect estimates into a Bayesian survival trial: a simulation study.将个体历史对照和综合治疗效果估计纳入贝叶斯生存试验:一项模拟研究。
BMC Med Res Methodol. 2019 Apr 24;19(1):85. doi: 10.1186/s12874-019-0714-z.
5
Bayesian adaptive randomization design incorporating propensity score-matched historical controls.贝叶斯自适应随机化设计,结合倾向评分匹配的历史对照。
Pharm Stat. 2022 Sep;21(5):1074-1089. doi: 10.1002/pst.2203. Epub 2022 Mar 12.
6
A novel power prior approach for borrowing historical control data in clinical trials.一种在临床试验中借用历史对照数据的新型功率先验方法。
Stat Methods Med Res. 2023 Mar;32(3):493-508. doi: 10.1177/09622802221146309. Epub 2023 Jan 4.
7
Bayesian dynamic borrowing in group-sequential design for medical device studies.医疗器械研究成组序贯设计中的贝叶斯动态借用法
BMC Med Res Methodol. 2025 Mar 20;25(1):78. doi: 10.1186/s12874-025-02520-6.
8
Bayesian adaptive design for pediatric clinical trials incorporating a community of prior beliefs.贝叶斯适应性设计在儿科临床试验中的应用,该设计结合了社区的先验信念。
BMC Med Res Methodol. 2022 Apr 21;22(1):118. doi: 10.1186/s12874-022-01569-x.
9
An efficient Bayesian platform trial design for borrowing adaptively from historical control data in lymphoma.用于淋巴瘤中从历史对照数据自适应借用的高效贝叶斯平台试验设计
Contemp Clin Trials. 2020 Feb;89:105890. doi: 10.1016/j.cct.2019.105890. Epub 2019 Nov 15.
10
Bayesian adaptive design for covariate-adaptive historical control information borrowing.贝叶斯自适应设计用于协变量自适应历史对照信息借用。
Stat Med. 2023 Dec 20;42(29):5338-5352. doi: 10.1002/sim.9913. Epub 2023 Sep 26.

引用本文的文献

1
Incorporating historic information to further improve power when conducting Bayesian information borrowing in basket trials.在篮子试验中进行贝叶斯信息借鉴时纳入历史信息以进一步提高检验效能。
Biostatistics. 2024 Dec 31;26(1). doi: 10.1093/biostatistics/kxaf016.
2
Control of Unconditional Type I Error in Clinical Trials With External Control Borrowing-A Two-Stage Adaptive Design Perspective.采用外部对照借用的临床试验中无条件I型错误的控制——两阶段自适应设计视角
Pharm Stat. 2025 May-Jun;24(3):e70011. doi: 10.1002/pst.70011.
3
Bayesian analysis of the rate of spontaneous malignant mesothelioma among BAP1 mutant mice in the absence of asbestos exposure.

本文引用的文献

1
Predictively consistent prior effective sample sizes.可预测一致性先验有效样本量。
Biometrics. 2020 Jun;76(2):578-587. doi: 10.1111/biom.13252. Epub 2020 Apr 6.
2
Model averaging for robust extrapolation in evidence synthesis.模型平均在证据综合中的稳健外推。
Stat Med. 2019 Feb 20;38(4):674-694. doi: 10.1002/sim.7991. Epub 2018 Oct 10.
3
Bayesian clinical trial design using historical data that inform the treatment effect.基于历史数据信息进行治疗效果推断的贝叶斯临床试验设计。
在无石棉暴露情况下对BAP1突变小鼠自发性恶性间皮瘤发生率的贝叶斯分析。
Sci Rep. 2025 Jan 2;15(1):169. doi: 10.1038/s41598-024-84069-w.
4
Evaluation of the Fill-it-up-design to use historical control data in randomized clinical trials with two arm parallel group design.评价 Fill-it-up 设计在具有两臂平行组设计的随机临床试验中使用历史对照数据的方法。
BMC Med Res Methodol. 2024 Sep 9;24(1):197. doi: 10.1186/s12874-024-02306-2.
5
On the use of non-concurrent controls in platform trials: a scoping review.在平台试验中使用非同期对照:范围综述。
Trials. 2023 Jun 15;24(1):408. doi: 10.1186/s13063-023-07398-7.
6
Being Bayesian in the 2020s: opportunities and challenges in the practice of modern applied Bayesian statistics.21 世纪的贝叶斯主义者:现代应用贝叶斯统计学实践中的机遇与挑战。
Philos Trans A Math Phys Eng Sci. 2023 May 15;381(2247):20220156. doi: 10.1098/rsta.2022.0156. Epub 2023 Mar 27.
7
A Bayesian group sequential design for randomized biosimilar clinical trials with adaptive information borrowing from historical data.用于随机生物类似药临床试验的贝叶斯分组序贯设计,具有从历史数据中自适应信息借鉴的功能。
J Biopharm Stat. 2022 May 4;32(3):359-372. doi: 10.1080/10543406.2022.2080700. Epub 2022 Jun 9.
8
INNODIA Master Protocol for the evaluation of investigational medicinal products in children, adolescents and adults with newly diagnosed type 1 diabetes.英诺达研究方案:评价新诊断 1 型糖尿病儿童、青少年和成人患者中研究性药物。
Trials. 2022 May 18;23(1):414. doi: 10.1186/s13063-022-06259-z.
9
A stochastically curtailed single-arm phase II trial design for binary outcomes.针对二分类结局的随机截尾单臂二期临床试验设计。
J Biopharm Stat. 2022 Sep 3;32(5):671-691. doi: 10.1080/10543406.2021.2009498. Epub 2022 Jan 25.
Biostatistics. 2019 Jul 1;20(3):400-415. doi: 10.1093/biostatistics/kxy009.
4
A Calibrated Power Prior Approach to Borrow Information from Historical Data with Application to Biosimilar Clinical Trials.一种校准功率先验方法:从历史数据中借用信息并应用于生物类似药临床试验
J R Stat Soc Ser C Appl Stat. 2017 Nov;66(5):979-996. doi: 10.1111/rssc.12204. Epub 2016 Dec 23.
5
Adaptive power priors with empirical Bayes for clinical trials.用于临床试验的具有经验贝叶斯的自适应功率先验
Pharm Stat. 2017 Sep;16(5):349-360. doi: 10.1002/pst.1814. Epub 2017 Jun 2.
6
The power prior: theory and applications.功率先验:理论与应用。
Stat Med. 2015 Dec 10;34(28):3724-49. doi: 10.1002/sim.6728. Epub 2015 Sep 7.
7
Robust meta-analytic-predictive priors in clinical trials with historical control information.具有历史对照信息的临床试验中的稳健元分析预测先验。
Biometrics. 2014 Dec;70(4):1023-32. doi: 10.1111/biom.12242. Epub 2014 Oct 29.
8
Commensurate Priors for Incorporating Historical Information in Clinical Trials Using General and Generalized Linear Models.使用广义线性模型和广义线性模型在临床试验中纳入历史信息的相称先验。
Bayesian Anal. 2012 Aug 28;7(3):639-674. doi: 10.1214/12-BA722.
9
Use of historical control data for assessing treatment effects in clinical trials.在临床试验中使用历史对照数据评估治疗效果。
Pharm Stat. 2014 Jan-Feb;13(1):41-54. doi: 10.1002/pst.1589. Epub 2013 Aug 5.
10
Adaptive adjustment of the randomization ratio using historical control data.利用历史对照数据进行随机化比例的适应性调整。
Clin Trials. 2013;10(3):430-40. doi: 10.1177/1740774513483934.